ANDROID-F Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Android-f, and when can generic versions of Android-f launch?
Android-f is a drug marketed by Valeant Pharm Intl and is included in one NDA.
The generic ingredient in ANDROID-F is fluoxymesterone. There is one drug master file entry for this compound. Additional details are available on the fluoxymesterone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ANDROID-F?
- What are the global sales for ANDROID-F?
- What is Average Wholesale Price for ANDROID-F?
Summary for ANDROID-F
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 47 |
| Clinical Trials: | 10 |
| Patent Applications: | 4,958 |
| DailyMed Link: | ANDROID-F at DailyMed |
Recent Clinical Trials for ANDROID-F
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| St. Olavs Hospital | Phase 4 |
| Oslo University Hospital | Phase 4 |
| Haukeland University Hospital | Phase 4 |
US Patents and Regulatory Information for ANDROID-F
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharm Intl | ANDROID-F | fluoxymesterone | TABLET;ORAL | 087196-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
